Latest news with #World'sBest
Newsweek
05-05-2025
- Entertainment
- Newsweek
A Nice Indian Boy Gets New Digital Release Date
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Entertainment gossip and news from Newsweek's network of contributors A charming new rom-com starring Karan Soni and Jonathan Groff hit theaters last month, A Nice Indian Boy, which features a whirlwind romance, sweet humor, and plenty of dancing. Its theatrical release was limited, so you may not have had the chance to see it just yet, but that can be remedied from May 6, when A Nice Indian Boy becomes available to rent and buy on Video on Demand platforms. Harish Patel as Archit Gavaskar, Karan Soni as Naveen Gavaskar, Zarna Garg as Megha Gavaskar, Sunita Mani as Arundhathi Gavaskar in A Nice Indian Boy. Harish Patel as Archit Gavaskar, Karan Soni as Naveen Gavaskar, Zarna Garg as Megha Gavaskar, Sunita Mani as Arundhathi Gavaskar in A Nice Indian Boy. Courtesy of Levantine Films READ: INTERVIEW: "I Felt Like I Could Completely Be Myself" – Karan Soni & Jonathan Groff Discuss A Nice Indian Boy A Nice Indian Boy is the third directorial effort from Roshan Sethi, whose previous films include 7 Days and World's Best. We've got the full details below on where to watch A Nice Indian Boy, A Nice Indian Boy physical release date, and when will A Nice Indian Boy be on streaming. Where Can I Watch A Nice Indian Boy? A Nice Indian Boy will be available to rent and buy across Video on Demand platforms from May 6. You will be able to find the film on platforms such as Prime Video, Apple TV, and Fandango at Home. A Nice Indian Boy Physical Release Date A Nice Indian Boy does not yet have an expected 4K Ultra HD, Blu-ray, and DVD release date. Is A Nice Indian Boy Available to Stream in the US? A Nice Indian Boy is not currently on any streaming services in the US. However, it will likely find a home on a streaming platform in the future.
New Straits Times
24-04-2025
- Health
- New Straits Times
Putrajaya Holdings, Sunway Healthcare to build private hospital in Precinct 7
KUALA LUMPUR: Putrajaya Holdings Sdn Bhd (PjH) and Sunway Healthcare Holdings Sdn Bhd (SHH) have signed a heads of agreement to jointly develop a private tertiary medical centre in Precinct 7, Putrajaya. The facility will offer more than 300 beds and advanced specialist services, including a dedicated burns unit. It is expected to serve residents of Putrajaya, the greater southern Klang Valley, and international patients. PjH chief executive officer Datuk Izwan Isli Mohd Ibrahim said Precinct 7 was selected for its connectivity via Putrajaya Sentral and its proximity to medical institutions. This includes Putrajaya Hospital, the National Cancer Institute and the Medical Academies of Malaysia. "This marks a catalytic milestone in Putrajaya's growth journey, and we are excited to collaborate with a trusted partner like Sunway Healthcare to bring this shared vision to life," he said in a joint statement today. SHH group president Datuk Lau Beng Long said the partnership would allow the community better access to comprehensive private healthcare services. "Citing Sunway as recent Malaysia top medical centre ranking in Newsweek's World's Best Hospitals 2025 list, we will strive to provide excellent facilities and compassionate, patient‑centred medical care," he said. The hospital is part of broader efforts to enhance specialist care infrastructure in the federal administrative capital and support Putrajaya's goal of becoming a regional centre for quality medical services.
Los Angeles Times
19-04-2025
- Health
- Los Angeles Times
Precision Medicine, AI and Smart Exosomes: How Taiwan is Reshaping Global Healthcare
In central Taiwan, one of Asia's most technologically advanced hospitals is setting new standards in precision medicine, digital transformation and biomedical innovation, attracting attention from U.S. clinical researchers and global pharmaceutical partners. Founded in 1958, China Medical University Hospital (CMUH) operates a 2,062-bed facility, managing 200,000 outpatient visits, 11,000 emergency cases and 5,900 surgeries every month. The hospital's consistent innovation has earned it a place on Newsweek's World's Best Hospitals 2023-2024 and World's Best Smart Hospitals 2024-2025. 'Since 2017, we've built a comprehensive digital framework that meets the highest international standards,' says Dr. Wei-Cheng Chen, Chief Secretary of CMUH. The hospital holds four major HIMSS certifications – INFRAM Stage 7, EMRAM Stage 7, AMAM Stage 7 and DIAM Stage 6 – making it the only hospital in Taiwan with this complete set. In 2023, CMUH also topped the Digital Health Indicator, becoming the highest-ranked hospital globally and the only Asian institution to achieve this. This digital infrastructure directly supports CMUH's leadership in CAR-T therapy, medical AI, and exosome research, all areas where the hospital is pushing the boundaries of clinical science. 'We developed the first allogeneic CAR-BiTE GDT therapy for solid tumors, moving beyond liquid cancers into much harder-to-treat areas,' explains Dr. Der-Yang Cho, Superintendent of CMUH. The therapy has already secured FDA approval for clinical trials. Medical AI also plays a central role, supporting diagnostics, risk prediction, and treatment planning across departments. 'From real-time sepsis prediction to AI-assisted ICD coding, our systems help doctors make faster, better decisions every day,' says Chen. Among CMUH's most ambitious innovations is its work with Smart Exosomes, redefining these cellular vesicles as precision drug carriers. 'Our exosomes can deliver DNA, RNA, peptides and proteins directly to targeted organs, from the brain to the heart, enhancing efficacy by up to 90 times while reducing side effects,' says Cho. CMUH's commitment to innovation is reflected in its unmatched 17 awards at the 21st Taiwan National Innovation Awards and 35 honors at the 24th National Healthcare Quality Awards, making it the most awarded hospital in both competitions. 'Following the model of Mayo Clinic, we send our doctors to top 10 global hospitals to master advanced techniques, ensuring that talent drives innovation,' says Cho. 'Talent is very important. We want to lead Taiwan by focusing on both talent and new technology.'
Mid East Info
30-03-2025
- Health
- Mid East Info
56-Year-Old Woman Undergoes Scar-Free Hysterectomy at Aster Hospital Al Qusais Using Advanced vNOTES Technique
Aster Hospital Al Qusais, recognized in Newsweek's 'World's Best Smart Hospitals 2025' List among 350 hospitals globally and ranked No. 14 on Newsweek's World's Best Hospitals in the UAE list, successfully performed a groundbreaking hysterectomy using a scar-free, minimally invasive technique known as Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES). This advanced procedure eliminates the need for cuts on the abdomen, allowing for faster recovery, reduced pain, and improved surgical precision. The surgery was performed on 56-year-old Ms. Sarojadevi Selvaraja, an Indian national, who was experiencing unusual postmenopausal bleeding for some time. After experiencing irregular spotting for two years, she had a more severe episode in January, which prompted her to seek medical advice. A thorough evaluation revealed precancerous changes in the uterine lining, which, if untreated, could lead to further complications. Given her previous medical history, including high blood pressure and past gynecological procedures, her doctors recommended hysterectomy. Since she preferred a less invasive approach, the expert medical team at Aster Hospital Al Qusais, led by Dr. Fathima Safa, Specialist in Obstetrics & Gynecology, chose the vNOTES technique, ensuring a smoother recovery and better cosmetic results. While hysterectomies are most common in women between the ages of 40 and 49, performing this type of scar-free surgery on an older patient highlights the hospital's expertise in handling complex cases with the latest medical advancements. 2 Unlike traditional surgery, which requires cuts on the abdomen, vNOTES allows doctors to remove the uterus, fallopian tubes, and ovaries through the natural vaginal opening. A specialized device creates a working space, allowing the surgical team to use a tiny camera and advanced instruments to carefully perform the procedure with minimal bleeding. During the procedure, doctors carefully removed the uterus, fallopian tubes, and ovaries using a minimally invasive approach that required no abdominal incisions. Advanced technology ensured precision, minimal bleeding, and faster healing. Thanks to the vNOTES technique, Ms. Sarojadevi experienced little discomfort and was able to leave the hospital within a day, resuming her daily routine much sooner than with traditional surgery. Dr. Fathima Safa, Specialist in Obstetrics & Gynecology, Aster Hospital Al Qusais highlighted the importance of using advanced techniques in gynecological surgery. She stated, 'vNOTES is the future of minimally invasive procedures, combining the benefits of traditional vaginal surgery with the precision of modern techniques. This results in quicker recovery, less pain, and no visible scars. While laparoscopic and robotic-assisted surgeries are commonly used, vNOTES takes it a step further by eliminating external incisions entirely, making it a significant breakthrough in gynecologic surgery.' Dr. Aysha Salam, Specialist in Obstetrics & Gynecology at Aster Hospital Sharjah, added, 'This technique is a game-changer for women who need gynecologic surgery. It shortens recovery time, reduces post-surgery discomfort, and significantly improves overall patient experience. Aster Hospitals is committed to bringing innovative and patient-friendly surgical solutions to enhance women's healthcare.' Expressing her gratitude, Ms. Sarojadevi said, 'I was initially worried about having surgery, but the doctors reassured me about the benefits of this advanced approach. With no visible scars, little pain, and a quick recovery, I felt at ease and deeply appreciated the care and expertise of Dr. Fathima Safa, Dr. Aysha Salam, and the entire medical team.' The vNOTES technique offers several advantages over traditional surgery. Since it is performed through the vaginal canal, patients have no visible scars, experience faster recovery, and can return to normal activities sooner. In fact, many patients are able to return to work within 2 to 3 weeks, while others may need 4 to 6 weeks, depending on their recovery. Post-surgery discomfort is minimal, reducing the need for strong pain medication. The use of a small camera provides a clear, detailed view, allowing for safer and more precise surgery while lowering the risk of complications such as excessive bleeding or internal scar tissue. Recent studies have shown that vNOTES hysterectomy results in shorter operation times, less pain after surgery, and fewer complications compared to traditional laparoscopic hysterectomy. Since receiving approval from the U.S. Food and Drug Administration (FDA) in 2019, the technique has gained international recognition and is being used for a variety of gynecologic procedures, including the removal of ovarian cysts, treatment of ectopic pregnancies, and surgeries to improve pelvic support. 1 vNOTES is a great option for many patients, but it may not be suitable for those with certain medical conditions, like severe endometriosis, previous colorectal surgery, or pelvic radiation. However, for those who are eligible, vNOTES offers a safer and faster recovery with fewer scars and less pain Aster Hospital Al Qusais remains at the forefront of medical innovation, ensuring that patients receive the highest standard of care with the most advanced and patient-friendly surgical options available.
Khaleej Times
30-01-2025
- Sport
- Khaleej Times
First Conquest to uphold Godolphin honour in Dubai Millennium Stakes
It's fitting that a race named after one of their all-time greats has become a happy hunting ground for Godolphin, and the Dubai-based operation aims for an eleventh win in Friday's G3 Dubai Millennium Stakes. Charlie Appleby has won the race eight times, including the last seven, with his roll of honour including such greats as Ghaiyyath, crowned the Longines World's Best Horse in 2020. This year's runner, First Conquest, isn't quite in his league just yet but was taking when overcoming a slow break and a wide draw in the Lord North Handicap last time out. 'First Conquest won impressively on his first start in Dubai and has come forward for the run,' said Appleby. 'He is stepping into Pattern company and it will be interesting to see how he copes with the rise in class. 'We are dipping our toe at this level to see where his future lies and will hopefully be a lot wiser afterwards.' First Conquest's nine rivals include 'miracle horse' Asaassi, who continued his comeback from a career-threatening injury when the impressive winner of a course and distance handicap four weeks' ago. 'When he came over [from the UK] he had a mystery slice through a tendon and the vets didn't think he'd make it,' said trainer Michael Costa. 'We took last season to just do some foundation work with him and this season he's just continued to improve. 'He's really strengthened up and we're really happy with him. He's been quite on the bridle [keen] in his runs so he's still learning to relax and breathe a bit but he's a very happy horse at the moment. 'He's built up a good association with Ray Dawson, too.' Jamie Osborne runs See Hector, who put in a promising local debut when second to First Conquest. 'He ran very well,' he said. 'We hadn't had him very long and we're still finding out about him, so he ran a really strong race. 'He physically looks a lot better now than he did going into the Lord North, so I'd like to think he's a horse who can progress through the next few runs.' Sean, second to Warren Point in this race last year, also takes his chance for Osborne. 'Sean was just touched off in the Dubai Millennium last year, so he deserves another go,' added the trainer. The main supporting race is the Listed Dubai Sprint (sponsored by Emaar), worth Dh 500,000, which has attracted a field of 11 for the 1200metre turf dash. One of the more interesting runners is G3 winner Romantic Style, who drops in trip and class after finishing second in the G2 Cape Verdi over a mile last time out. 'The Cape Verdi was a messy race, and a mile has always been a slight question mark for Romantic Style in terms of whether she truly sees the trip out,' said trainer Appleby. 'She has strengthened over the winter and dropping back to sprinting could be her gig, looking at her pedigree. She goes into this in great shape, and it will open a few doors if she handles the drop in distance.' Also dropping in trip is Echo Point, impressive winner of a 1400metre handicap last time out. 'To me he's a horse who could go to a mile, but at the same time he's got plenty of speed,' said jockey Silvestre de Sousa. 'He's had plenty of racing, but I still feel he's learning about things.' The Mawj Stakes is a new addition to the Carnival programme this year and the 1400metre three-year-old fillies' event has attracted a field of ten. Among them is Octans, who brings a four-for-six record to the Carnival, her victories all coming at La Zarzuela in Spain. 'She is a lovely filly, she's done everything right from the start,' said trainer Guillermo Arizkorreta. 'She was the best two-year-old filly in Spain, but she's hard to assess against other fillies. I suppose Godolphin's (Mountain Breeze) and Barberot's (Lhakpa) will be hard to beat. There are two British runners in the field; Naana's Diamond, trained by Alice Haynes, and Osborne's Secret Combination, who reverts to turf after finding things tough on dirt last time. 'Secret Combination was moderate on the dirt but she's worked very well on the grass,' said the trainer. The closing Jumeirah Guineas Trial, over 1600metres on turf, sees the return of Appleby's G1 Summer Stakes runner-up Al Qudra, who looks the clear pick on form. Breaking from stall one in the field of ten is The Fingal Raven, who finished third last time over course and distance in the Jumeirah Stakes. 'I love this horse as I've said many times,' said trainer Osborne. 'I think he's got a tremendous amount of ability. He just ran a bit fresh and a bit free on his first start and set it up for (winner Age Of Gold) last time. 'We'll probably run him in a hood just to switch him off a little bit over the mile. He's probably going to be rated 10lbs below the Godolphin horses, but I still have belief he can step up and compete with them.' Pioneering Czech trainer Lucie Botti runs Blewburton, who makes his Meydan debut after five runs in the UK. 'Blewburton is a late addition to our stable and settled in nicely,' she said. 'He's facing a significant challenge in this very competitive renewal, but securing some prize money would be an exceptional achievement for his very enthusiastic owner Muhannad Saleh Al Maskari.'
